These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 18268002)

  • 1. Approaches to help people with diabetes overcome barriers for improved health outcomes.
    Siminerio LM
    Diabetes Educ; 2008; 34 Suppl 1():18S-24S. PubMed ID: 18268002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pen devices to improve patient adherence with insulin therapy in type 2 diabetes.
    Goldstein HH
    Postgrad Med; 2008 Sep; 120(3):172-9. PubMed ID: 18824835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving treatment satisfaction and other patient-reported outcomes in people with type 2 diabetes: the role of once-daily insulin glargine.
    Bradley C; Gilbride CJ
    Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():50-65. PubMed ID: 18577157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers to effective insulin treatment: the persistence of poor glycemic control in type 2 diabetes.
    Ross SA; Tildesley HD; Ashkenas J
    Curr Med Res Opin; 2011 Nov; 27 Suppl 3():13-20. PubMed ID: 21942467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving patient acceptance and adherence in diabetes management: a focus on insulin therapy.
    Rakel RE
    Adv Ther; 2009 Sep; 26(9):838-46. PubMed ID: 19768641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin therapy for maximal glycemic control in type 2 diabetes mellitus.
    Spellman CW
    J Am Osteopath Assoc; 2007 Jul; 107(7):260-9. PubMed ID: 17682113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic strategies for improved outcomes for the hyperglycemic hospitalized patient with diabetes mellitus.
    Vasa F
    Am J Cardiol; 2005 Aug; 96(4A):41E-46E. PubMed ID: 16098843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers to insulin initiation and intensification and how to overcome them.
    Kunt T; Snoek FJ
    Int J Clin Pract Suppl; 2009 Oct; (164):6-10. PubMed ID: 19751453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unlocking the opportunity of tight glycaemic control. Far from goal.
    Del Prato S
    Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S1-4. PubMed ID: 16135133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.
    Caballero AE
    J Diabetes Complications; 2009; 23(2):143-52. PubMed ID: 18413192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breaking the barriers to optimal glycaemic control--what physicians need to know from patients' perspectives.
    Snoek FJ
    Int J Clin Pract Suppl; 2002 Jul; (129):80-4. PubMed ID: 12166612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DIAB.&TE.S Project: how patients perceive diabetes and diabetes therapy.
    Marra G;
    Acta Biomed; 2004 Dec; 75(3):164-70. PubMed ID: 15796090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementing an intravenous insulin protocol in your practice: practical advice to overcome clinical, administrative, and financial barriers.
    Kelly JL; Hirsch IB; Furnary AP
    Semin Thorac Cardiovasc Surg; 2006; 18(4):346-58. PubMed ID: 17395032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of inhaled insulin in the treatment of type 2 diabetes.
    Davis SN
    J Diabetes Complications; 2008; 22(6):420-9. PubMed ID: 18413196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus.
    Braun A; Sämann A; Kubiak T; Zieschang T; Kloos C; Müller UA; Oster P; Wolf G; Schiel R
    Patient Educ Couns; 2008 Oct; 73(1):50-9. PubMed ID: 18583087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhaled human insulin (Exubera): a revolution?].
    Daubresse JC; Sternon J
    Rev Med Brux; 2006; 27(6):493-7. PubMed ID: 17256415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological insulin resistance in geriatric patients with diabetes mellitus.
    Bahrmann A; Abel A; Zeyfang A; Petrak F; Kubiak T; Hummel J; Oster P; Bahrmann P
    Patient Educ Couns; 2014 Mar; 94(3):417-22. PubMed ID: 24341962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin glargine and glulisine SoloSTAR pens for the treatment of diabetes.
    Garg S; Kelly WC; Garg S
    Expert Rev Med Devices; 2008 Mar; 5(2):113-23. PubMed ID: 18331174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing insulin therapy in patients with type 1 and type 2 diabetes mellitus: optimal dosing and timing in the outpatient setting.
    Hahr AJ; Molitch ME
    Am J Ther; 2008; 15(6):543-50. PubMed ID: 19127139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.